Key result
Drug-induced prolongation of the QT interval is a significant regulatory concern.
Key points are not available for this paper at this time.
The views expressed in this paper are those of the author and do not necessarily represent the views or the opinions of Medicines Control Agency, other regulatory authorities or any of their advisory committees.
No takes yet. Share an insight, caveat, or question.
Rashmi R. Shah (2002) studied this question. Drug-induced prolongation of the QT interval is a significant regulatory concern.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: